Eric Karas insider trades

Open-market stock purchases and sales by Eric Karas, Chief Commercial Officer at ARS Pharmaceuticals, Inc, from SEC Form 4 filings since Nov 8, 2022.

Recent trades

DateStockTradeValue
Jun 12, 2026SPRY ARS Pharmaceuticals, IncSold$250K
Jun 12, 2026SPRY ARS Pharmaceuticals, IncBought (not open market)—
Jan 2, 2026SPRY ARS Pharmaceuticals, IncBought (not open market)—

Companies traded

  • SPRY ARS Pharmaceuticals, Inc: 8 sales, last Jun 12, 2026

Get free alerts when Eric Karas files a new trade →